Clinical trial
Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator…
NCT00455585 · Makerere University, Other · Completed
Key facts
| NCT number | NCT00455585 |
|---|---|
| Title | Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products |
| Official title | Comparison of the Steady State Pharmacokinetics of Nevirapine, Stavudine Plus Lamivudine in HIV Positive Ugandan Patients Taking Triomune 40 With the Pharmacokinetics of the Originator Products. |
| Lead sponsor | Makerere University, Other |
| Collaborators | Department of Foreign Affairs, Ireland |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | nevirapine, stavudine, lamivudine |
| Enrollment | 18 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Apr 3, 2007 |
| Last update posted | Feb 8, 2008 |
| Countries | Uganda |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: